Abstract : Lead was administered to pregnant rats in drinking water (5 ppm) from day 1 to day 18 or 21 of gestation, at which time the dams and fetuses were sacrificed.
INTRODUCTION
In a previous paper, the author1) reported the effects of lead on hematological parameters (red blood cell count, packed cell volume and hemoglobin concentration) and biochemical parameters (ALAD activities of the blood, liver and placenta) of the heme biosynthetic pathway in dams and fetuses following the administration of drinking water containing a high concentration (500 ppm) of lead to pregnant rats. He pointed out that (1) lead was transferred readily from the mother to the fetus, (2) lead had no apparently ill effects on the rats in the course of pregnancy, (3) the red blood cell count and hemoglobin concentration were markedly reduced in the lead-treated fetuses, but not in the lead-treated dams, and (4) erythrocyte ALAD activity was significantly lower in both leadtreated dams and fetuses than in untreated controls. The results suggest that a strong inhibition of heme synthesis may have already occurred in the fetus.
Human beings, however, do not experience oral ingestion of a large amount of lead in normal daily life. Exposure to a low concentration of lead from the atomsphere and food is a serious problem in living organisms2-3). With the same biochemical parameters as adopted before1), this study was carried out to elucidate the effects of a low lead level on pregnant rats and their fetuses. Table 5 presents a correlation matrix that expresses the correlation between any two parameters in the dams and in the fetuses. In the dams, significant positive correlations were observed among the lead levels of the blood, liver, and placenta.
MATERIALS AND METHODS
On the other hand, significant negative correlations were found between blood lead and liver ALAD activity, between liver lead and erythrocyte ALAD activity, and between placenta lead and erythrocyte ALAD activity.
In the fetuses, blood lead level is correlated with liver and placenta lead, or with liver ALAD activity. Liver lead level is correlated with placenta lead, or with erythrocyte and liver ALAD activity. Furthermore, ALAD activity in the fetal erythrocytes correlated with placenta lead and liver ALAD activity.
Statistically significant positive correlations were found between dams and fetuses in blood lead level (Fig. 1) , liver lead level (Fig. 2) , and erythrocyte ALAD activity (Fig. 3) . There was a significant negative correlation between the maternal and fetal liver ALAD activity (Fig. 4) entered the blood stream, but, since the lead rapidly moved to the liver and other traget organs, the blood lead level did not increase. The lead level of the blood in the lead-treated fetuses was significantly higher on day 18 than on day 21 of gestation. On the other hand, the lead level of the placenta in the lead-treated groups was significantly increased. These observations suggest that lead is easily transferred from the dams to the fetuses during the early phase of gestation and is blocked by the placenta during later gestation stages. The same idea might be applied to the control fetuses, i.e., it was considered that lead stored in the dams before mating may rapidly shift to embryos when the placental formation is not complete.
The difference in the elevated liver ALAD in the fetus compared with that in the adult may be explained as follows: (1) ALAD and ALA synthetase activities are greatest in the liver4,5); (2) the activity of ALA synthetase is 10 times higher in the fetal rat liver than in adults° and (3) hemin injection depresses liver ALA synthetase activity in the adult, but not in the fetus7).
The author has reported that the hepatic ALAD activity was reduced when the liver lead levels in the dams and their litters were 17 and 27 times higher than normal, respectively8). Therefore, the liver ALAD activity is not hindered when the subject is exposed to only a small amount of lead. The data in this study confirm the sensitivity of ALAD to intoxication by lead. The reduction of ALAD activity found in the fetuses is, however, much smaller than that seen in the erythrocytes of the dams. Kuhnert et al.9) pointed out that greater cell volume of the fetal erythrocytes allows a corespondingly greater amount of the cytoplasmic enzyme ALAD. As a result, the fetal erythrocyte ALAD activity may be suppressed to a lesser extent than that of the dams. In addition to a reduction of erythrocyte ALAD activity, however, a decrease of the RBC count, Hb concentration and a retardation in body growth were observed in the lead-treated fetuses. Jaquet et al.10) and Gerber and Maes11) reported that the impaired synthesis of heme in lead-intoxicated mouse embryos appears to be sufficient for the reduction of their body mass during the late phase of gestation.
From the facts described above, lead exposure during pregnancy should be assumed to influence the fetus, even though it may be such a low level that clinical signs of poisoning are not observed. 
